Reported results
- R&D expense for the third quarter of 2026 was $4.9 million.
- G&A expense for the third quarter of 2026 was $3.6 million.
- Net loss for the third quarter of 2026 was $8.0 million.
- Net loss per share (basic and diluted) for the third quarter of 2026 was $0.30.
- Cash and cash equivalents were $30.9 million as of September 30, 2026.
Guidance
- The Company expects that its current cash and cash equivalents will support operations into the second quarter of 2027.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
